Introduction: The functions and mechanisms of prion proteins (PrPC) are currently unknown, but most experts believe that deformed or pathogenic prion proteins (PrPSc) originate from PrPC, and that there may be plural main sites for the conversion of normal PrPC into PrPSc. In order to better understand the mechanism of PrPC transformation to PrPSc, the most important step is to determine the replacement or substitution site.
Material and Methods: BALB/c mice were challenged with prion RML strain and from 90 days post-challenge (dpc) mice were sacrificed weekly until all of them had been at 160 dpc. The ultra-structure and pathological changes of the brain of experimental mice were observed and recorded by transmission electron microscopy.
Results: There were a large number of pathogen-like particles aggregated in the myelin sheath of the brain nerves, followed by delamination, hyperplasia, swelling, disintegration, phagocytic vacuolation, and other pathological lesions in the myelin sheath. The aggregated particles did not overflow from the myelin in unstained samples. The phenomenon of particle aggregation persisted all through the disease course, and was the earliest observed pathological change.
Conclusion: It was deduced that the myelin sheath and lipid rafts in brain nerves, including axons and dendrites, were the main sites for the conversion of PrPC to PrPSc, and the PrPSc should be formed directly by the conversion of protein conformation without the involvement of nucleic acids.
1. Agostini F., Dotti C.G., Perez-Canamas A., Ledesma M.D., Benetti F., Legname G.: Prion protein accumulation in lipid rafts of mouse aging brain. PLoS One 2013, 8, e74244.
2. Aguzzi A., Calella A.M.: Prions: protein aggregation and infectious diseases. Physiol Rev 2009, 89, 1105–1152.
3. Baumann F., Tolnay M., Brabeck C., Pahnke J., Kloz U., Niemann H.H., Heikenwalder M., Rulicke T., Burkle A., Aguzzi A.: Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J 2007, 26, 538–547.
4. Brandner S., Raeber A., Sailer A., Blattler T., Fischer M., Weissmann C., Aguzzi A.: Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system. Proc Natl Acad Sci USA 1996, 93, 13148–13151.
5. Bueler H., Fischer M., Lang Y., Bluethmann H., Lipp H.P., DeArmond S.J., Prusiner, S.B., Aguet M., Weissmann C.: Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992, 356, 577–582.
6. Chen W., van der Kamp M.W., Daggett V.: Diverse effects on the native beta-sheet of the human prion protein due to disease-associated mutations. Biochemistry 2010, 49, 9874–9881.
7. Conforti L., Gilley J., Coleman M.P.: Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nat Rev Neurosci 2014, 15, 394–409.
8. Czarnik U., Strychalski J., Zabolewicz T., Pareek C.S.: Populationwide investigation of two indel polymorphisms at the prion protein gene in Polish Holstein-Friesian cattle. Biochem Genet 2011, 49, 303–312.
9. DeMarco M.L., Daggett V.: Local environmental effects on the structure of the prion protein. C R Biol 2005, 328, 847–862.
10. Dickinson A.G., Outram G.W.: Genetic aspects of unconventional virus infections: the basis of the virino hypothesis. Ciba Found Symp 1988, 135, 63–83.
11. Ersdal C., Goodsir C.M., Simmons M.M., McGovern G., Jeffrey M.: Abnormal prion protein is associated with changes of plasma membranes and endocytosis in bovine spongiform encephalopathy (BSE)-affected cattle brains. Neuropathol Appl Neurobiol 2009, 35, 259–271.
12. Ersdal C., Simmons M.M., Goodsir C., Martin S., Jeffrey, M.: Sub-cellular pathology of scrapie: coated pits are increased in PrP codon 136 alanine homozygous scrapie-affected sheep. Acta Neuropathol 2003, 106, 17–28.
13. Flannigan D.J., Zewail A.H.: 4D electron microscopy: principles and applications. Acc Chem Res 2012, 45, 1828–1839.
14. Frid K., Einstein O., Friedman-Levi Y., Binyamin O., Ben-Hur T., Gabizon R.: Aggregation of MBP in chronic demyelination. Ann Clin Transl Neurol 2015, 2, 711–721.
15. Fujita M., Kinoshita T.: Structural remodeling of GPI anchors during biosynthesis and after attachment to proteins. FEBS Lett 2010, 584, 1670–1677.
16. Gul N., Ozkorkmaz E.G., Kelesoglu I., Ozluk A.: An ultrastructural study, effects of Proteus vulgaris OX19 on the rabbit spleen cells. Micron 2013, 44, 133–136.
17. Gurgul A., Czarnik U., Larska M., Polak M.P., Strychalski J., Slota E.: Polymorphism of the prion protein gene (PRNP) in Polish cattle affected by classical bovine spongiform encephalopathy. Mol Biol Rep 2012, 39, 5211–5217.
18. Horonchik L., Tzaban S., Ben-Zaken O., Yedidia Y., Rouvinski A., Papy-Garcia D., Barritault D., Vlodavsky I., Taraboulos A.: Heparan sulfate is a cellular receptor for purified infectious prions. J Biol Chem 2005, 280, 17062–17067.
19. Jeffrey M., Goodsir C.M., Bruce M., McBride P.A., Scott J.R., Halliday W.G.: Correlative light and electron microscopy studies of PrP localisation in 87V scrapie. Brain Res 1994, 656, 329–343.
20. Jeffrey M., McGovern G., Goodsir C.M., Brown K.L., Bruce M.E.: Sites of prion protein accumulation in scrapie-infected mouse spleen revealed by immuno-electron microscopy. J Pathol 2000, 191, 323–332.
21. Jeffrey M., McGovern G., Siso S., Gonzalez L.: Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease. Acta Neuropathol 2011, 121, 113–134.
22. Juling K., Schwarzenbacher H., Frankenberg U., Ziegler U., Groschup M., Williams J.L., Fries R.: Characterization of a 320-kb region containing the HEXA gene on bovine chromosome 10 and analysis of its association with BSE susceptibility. Anim Genet 2008, 39, 400–406.
23. Kupfer L., Hinrichs W., Groschup M.H.: Prion protein misfolding. Curr Mol Med 2009, 9, 826–835.
24. Legname G., Nguyen H.O., Peretz D., Cohen F.E., DeArmond S.J., Prusiner S.B.: Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci USA 2006, 103, 19105–19110.
25. Liberski P.P., Brown D.R., Sikorska B., Caughey B., Brown P.: Cell death and autophagy in prion diseases (transmissible spongiform encephalopathies). Folia Neuropathol 2008, 46, 1–25.
26. Malik I., Turk J., Mancuso D.J., Montier L., Wohltmann M., Wozniak D.F., Schmid, R.E., Gross R.W., Kotzbauer P.T.: Disrupted membrane homeostasis and accumulation of ubiquitinated proteins in a mouse model of infantile neuroaxonal dystrophy caused by PLA2G6 mutations. Am J Pathol 2008, 172, 406–416.
27. Moore R.A., Taubner L.M., Priola S.A.: Prion protein misfolding and disease. Curr Opin Struct Biol 2009, 19, 14–22.
28. Okada H., Iwamaru Y., Fukuda S., Yokoyama T., Mohri S.: Detection of disease-associated prion protein in the optic nerve and the adrenal gland of cattle with bovine spongiform encephalopathy by using highly sensitive immunolabeling procedures. J Histochem Cytochem 2012, 60, 290–300.
29. Paulick M.G., Bertozzi C.R.: The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins. Biochemistry 2008, 47, 6991–7000.
30. Piccardo P., Cervenak J., Bu M., Miller L., Asher D.M.: Complex proteinopathy with accumulations of prion protein, hyperphosphorylated tau, alpha-synuclein and ubiquitin in experimental bovine spongiform encephalopathy of monkeys. J Gen Virol 2014, 95, 1612–1618.
31. Raju T.N.: The Nobel chronicles. 1997: Stanley Ben Prusiner (b 1942). Lancet 2000, 356, 260.
33. Sander P., Hamann H., Drogemuller C., Kashkevich K., Schiebel K., Leeb T.: Bovine prion protein gene (PRNP) promoter polymorphisms modulate PRNP expression and may be responsible for differences in bovine spongiform encephalopathy susceptibility. J Biol Chem 2005, 280, 37408–37414.
34. Santuccione A., Sytnyk V., Leshchyns'ka I., Schachner M.: Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol 2005, 169, 341–354.
35. Yuan A.H., Hochschild A.: A bacterial global regulator forms a prion. Science 2017, 355, 198–201.